Global and Region Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Benign Prostatic Hyperplasia (BPH) Treatment Devices market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devicesmarket, defines the market attractiveness level of Benign Prostatic Hyperplasia (BPH) Treatment Devices market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Benign Prostatic Hyperplasia (BPH) Treatment Devices industry, describes the types of Benign Prostatic Hyperplasia (BPH) Treatment Devices market, the applications of major players and the market size, and deeply analyzes the current situation of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market and the development prospects and opportunities of Benign Prostatic Hyperplasia (BPH) Treatment Devices industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market in Chapter 13.

    By Player:

    • Siemens (Germany)

    • NeoTract (US)

    • Boston Scientific (US)

    • Urologix (US)

    • Karl Storz (Germany)

    • Toshiba (Japan)

    • Urotech (Germany)

    • Olympus (Japan)

    • Lumenis (Israel)

    • Endo International (US)

    • Medtronic (US)

    • Baxter International (US)

    By Type:

    • Laser Based Procedure

    • Other Energy Based Procedure

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Analysis and Outlook to 2022

    • 7.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.2 United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.4 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.5 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.6 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    • 7.7 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption (2017-2022)

    8 Region and Country-wise Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Analysis and Outlook to 2028

    • 8.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.2 United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.4 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.5 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.6 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    • 8.7 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast (2022-2028)

    9 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Outlook by Types and Applications to 2022

    • 9.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Laser Based Procedure Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Other Energy Based Procedure Consumption and Growth Rate (2017-2022)

    • 9.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Outlook by Types and Applications to 2028

    • 10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Laser Based Procedure Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Other Energy Based Procedure Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Analysis

    • 14.1 Siemens (Germany)

      • 14.1.1 Siemens (Germany) Company Details

      • 14.1.2 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.2 NeoTract (US)

      • 14.2.1 NeoTract (US) Company Details

      • 14.2.2 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.3 Boston Scientific (US)

      • 14.3.1 Boston Scientific (US) Company Details

      • 14.3.2 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.4 Urologix (US)

      • 14.4.1 Urologix (US) Company Details

      • 14.4.2 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.5 Karl Storz (Germany)

      • 14.5.1 Karl Storz (Germany) Company Details

      • 14.5.2 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.6 Toshiba (Japan)

      • 14.6.1 Toshiba (Japan) Company Details

      • 14.6.2 Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.7 Urotech (Germany)

      • 14.7.1 Urotech (Germany) Company Details

      • 14.7.2 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.8 Olympus (Japan)

      • 14.8.1 Olympus (Japan) Company Details

      • 14.8.2 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.9 Lumenis (Israel)

      • 14.9.1 Lumenis (Israel) Company Details

      • 14.9.2 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.10 Endo International (US)

      • 14.10.1 Endo International (US) Company Details

      • 14.10.2 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.11 Medtronic (US)

      • 14.11.1 Medtronic (US) Company Details

      • 14.11.2 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • 14.12 Baxter International (US)

      • 14.12.1 Baxter International (US) Company Details

      • 14.12.2 Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Benign Prostatic Hyperplasia (BPH) Treatment Devices

    • Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Picture

    • Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Country (2017-2022)

    • Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Country (2022-2028)

    • Figure United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laser Based Procedure Consumption and Growth Rate (2017-2022)

    • Figure Global Other Energy Based Procedure Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Laser Based Procedure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Energy Based Procedure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Export by Region (Top 5 Countries) (2017-2028)

    • Table Siemens (Germany) (Foundation Year, Company Profile and etc.)

    • Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table NeoTract (US) (Foundation Year, Company Profile and etc.)

    • Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Boston Scientific (US) (Foundation Year, Company Profile and etc.)

    • Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Urologix (US) (Foundation Year, Company Profile and etc.)

    • Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Karl Storz (Germany) (Foundation Year, Company Profile and etc.)

    • Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Toshiba (Japan) (Foundation Year, Company Profile and etc.)

    • Table Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Urotech (Germany) (Foundation Year, Company Profile and etc.)

    • Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Olympus (Japan) (Foundation Year, Company Profile and etc.)

    • Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Lumenis (Israel) (Foundation Year, Company Profile and etc.)

    • Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Endo International (US) (Foundation Year, Company Profile and etc.)

    • Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Medtronic (US) (Foundation Year, Company Profile and etc.)

    • Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service

    • Table Baxter International (US) (Foundation Year, Company Profile and etc.)

    • Table Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.